Longitudinal uncoupling of cerebral perfusion, glucose metabolism, and tau deposition in Alzheimer's disease

Alzheimer's & Dementia - Tập 14 - Trang 652-663 - 2018
Antoine Leuzy1, Elena Rodriguez-Vieitez1, Laure Saint-Aubert1, Konstantinos Chiotis1, Ove Almkvist1,2,3, Irina Savitcheva4, My Jonasson5,6, Mark Lubberink5,6, Anders Wall5,7, Gunnar Antoni7, Agneta Nordberg1,2
1Division of Translational Alzheimer Neurobiology, Department of Neurobiology, Care Sciences, and Society, Karolinska Institutet, Stockholm, Sweden
2Department of Geriatric Medicine, Karolinska University Hospital, Huddinge, Sweden
3Department of Psychology, Stockholm University, Stockholm, Sweden
4Department of Radiology, Karolinska University Hospital, Huddinge, Sweden
5Radiology, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden
6Department of Medical Physics, Uppsala University Hospital, Uppsala, Sweden
7Department of Medicinal Chemistry, Uppsala University, Uppsala, Sweden

Tóm tắt

AbstractIntroduction

Cross‐sectional findings using the tau tracer [18F]THK5317 (THK5317) have shown that [18F]fluorodeoxyglucose (FDG) positron emission tomography (PET) data can be approximated using perfusion measures (early‐frame standardized uptake value ratio; ratio of tracer delivery in target to reference regions). In this way, a single PET study can provide both functional and molecular information.

Methods

We included 16 patients with Alzheimer's disease who completed follow‐up THK5317 and FDG studies 17 months after baseline investigations. Linear mixed‐effects models and annual percentage change maps were used to examine longitudinal change.

Results

Limited spatial overlap was observed between areas showing declines in THK5317 perfusion measures and FDG. Minimal overlap was seen between areas showing functional change and those showing increased retention of THK5317.

Discussion

Our findings suggest a spatiotemporal offset between functional changes and tau pathology and a partial uncoupling between perfusion and metabolism, possibly as a function of Alzheimer's disease severity.


Tài liệu tham khảo

10.1007/BF00841407 10.1001/archneur.1987.00520140035014 10.1097/00004728-198308000-00003 10.1212/01.WNL.0000163856.13524.08 10.1007/s11604-007-0132-8 Silverman DH, 2004, Brain 18F‐FDG PET in the diagnosis of neurodegenerative dementias: comparison with perfusion SPECT and with clinical evaluations lacking nuclear imaging, J Nucl Med, 45, 594 10.1038/jcbfm.2009.188 10.2967/jnumed.114.152405 10.1177/0271678X16645593 10.1097/00004647-200106000-00002 10.1097/00004647-199609000-00008 10.1006/nimg.1996.0066 10.1016/j.neuroimage.2007.03.004 Koeppe RA, 2005, 11C‐DTBZ and 18F‐FDG PET measures in differentiating dementias, J Nucl Med, 46, 936 10.2967/jnumed.115.168732 10.2967/jnumed.110.082057 10.1371/journal.pone.0139926 10.1186/s40478-015-0220-4 10.2967/jnumed.115.158519 Garibotto V, 2016, Erratum to: dual‐phase amyloid PET: hitting two birds with one stone, Eur J Nucl Med Mol Imaging, 43, 1747, 10.1007/s00259-016-3426-1 10.1007/s00259-016-3393-6 10.1007/s00259-016-3363-z 10.1186/s13195-016-0204-z KChiotis LSaint‐Aubert ERodriguez‐Vieitez ALeuzy OAlmkvist ISavitcheva et al.Longitudinal changes of tau PET imaging in relation to hypometabolism in prodromal and Alzheimer's disease dementia. Mol Psychiatry2017 May 16https://doi.org/10.1038/mp.2017.108. [Epub ahead of print] 10.1016/j.jalz.2011.03.005 10.1001/archneur.56.3.303 10.1016/S1474-4422(14)70090-0 10.1002/hbm.10123 10.1212/WNL.0b013e31827f0fd1 10.1093/brain/113.1.27 10.1038/jcbfm.1988.133 Chiu NT, 2004, Educational level influences regional cerebral blood flow in patients with Alzheimer's disease, J Nucl Med, 45, 1860 10.3233/JAD-121897 Smailagic N, 2015, (1)(8)F‐FDG PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI), Cochrane Database Syst Rev, 1, CD010632 Kogure D, 2000, Longitudinal evaluation of early Alzheimer's disease using brain perfusion SPECT, J Nucl Med, 41, 1155 10.1093/brain/awp132 10.1016/j.jalz.2014.05.855 10.1016/j.nbd.2014.08.016 10.1038/mp.2016.37 10.1007/s00401-016-1560-2 10.1002/ana.22248 Majerova P, 2014, Microglia display modest phagocytic capacity for extracellular tau oligomers, J Neuroinflammation, 11, 161, 10.1186/s12974-014-0161-z 10.2967/jnumed.110.087031 10.1038/nn.4492 10.1007/s00259-014-2919-z 10.1007/BF00308809 10.1371/journal.pone.0140311 10.1016/S1474-4422(12)70291-0 10.1212/WNL.0b013e3182840bbe 10.1177/0271678X16641128